CD8A and neoplasm: Furthermore, gene expression analysis of the TCGA-BRCA dataset indicated a significant reduction in CD8a expression within the high-IRRS group (Figure 4F), suggesting a diminished cytotoxic CD8+ T cell response, which is critical for anti-tumor immunity.